CAS
ANGO icon

CTC Alternative Strategies’s AngioDynamics ANGO Stock Holding History

CTC Alternative Strategies’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-12,600
Closed -$92.1K – 80
2023
Q3 		$92.1K Buy
+12,600
New +$105K 0.17% 60

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

CTC Alternative Strategies's ANGO Position: Q4 2023 in Review

CTC Alternative Strategies sold out of AngioDynamics (ANGO) in Q4 2023, closing a stake of 12,600 shares — an estimated $92.1K sold.

CTC Alternative Strategies first reported a position in ANGO in Q3 2023 and held it in 1 quarter. The position peaked at $92.1K in Q3 2023. 150 funds tracked by Wall St. Rank hold ANGO as of Q4 2023.

  • CTC Alternative Strategies reported no remaining AngioDynamics position as of Q4 2023 after selling out during the quarter.
  • CTC Alternative Strategies sold 12,600 AngioDynamics shares in Q4 2023, an estimated $92.1K.
  • CTC Alternative Strategies first reported a position in AngioDynamics in Q3 2023 and held it in 1 quarter.
  • CTC Alternative Strategies's AngioDynamics position peaked at $92.1K in Q3 2023.
  • 150 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2023.

Based on CTC Alternative Strategies's 13F filing for Q4 2023, filed 30 Jan 2024.